Karen Bernstein - 16 Feb 2022 Form 4 Insider Report for Codiak BioSciences, Inc.

Role
Director
Signature
/s/ Yalonda Howze, Attorney-in-Fact for Karen Bernstein
Issuer symbol
N/A
Transactions as of
16 Feb 2022
Net transactions value
$0
Form type
4
Filing time
18 Feb 2022, 15:06:13 UTC
Previous filing
04 Feb 2022
Next filing
12 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDAKQ Restricted Stock Units Award $0 +8,750 $0.000000 8,750 16 Feb 2022 Common Stock 8,750 See footnote F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 On February 16, 2022, David Flores and Karen Bernstein Trust Agreement was granted 8,750 restricted stock units, which vest on the first anniversary of the grant date.
F3 The reporting person is a trustee of David Flores and Karen Bernstein Trust Agreement.